HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pei-Lan Zong Selected Research

bedaquiline (R207910)

3/2021Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pei-Lan Zong Research Topics

Disease

1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
03/2021
1Extensively Drug-Resistant Tuberculosis
03/2021

Drug/Important Bio-Agent (IBA)

1bedaquiline (R207910)IBA
03/2021